Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen Dolan

Showing results (111-120 of 188) with videos related to

Pageof 19
Sort By:
Molecular Cancer Therapeutics|December 17, 2002
O6-benzylguanine-mediated enhancement of chemotherapyHenry S Friedman, Stephen Keir, Anthony E Pegg, et al.
Scientific Reports|January 17, 2018
Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung AdenocarcinomaEric R Gamazon, Matthew R Trendowski, Yujia Wen, et al.
Biochemical Pharmacology|May 12, 2009
The kinase inhibitor O6-cyclohexylmethylguanine (NU2058) potentiates the cytotoxicity of cisplatin by mechanisms that are independent of its effect upon CDK2Luke R E Harrison, Christopher J Ottley, D Graham Pearson, et al.
Nature Reviews. Drug Discovery|July 1, 2008
Creating and evaluating genetic tests predictive of drug responseScott T Weiss, Howard L McLeod, David A Flockhart, et al.
Genetic Epidemiology|May 7, 2014
Poly-omic prediction of complex traits: OmicKrigingHeather E Wheeler, Keston Aquino-Michaels, Eric R Gamazon, et al.
Genetics|June 25, 2013
Genome-wide variation of cytosine modifications between European and African populations and the implications for complex traitsErika L Moen, Xu Zhang, Wenbo Mu, et al.
Molecular Cancer Therapeutics|July 29, 2003
Enhancement of platinum-induced cytotoxicity by O6-benzylguanineMelissa L Fishel, Shannon M Delaney, Lindsay D Friesen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2009
Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokineticsFederico Innocenti, Deanna L Kroetz, Erin Schuetz, et al.
Human Molecular Genetics|June 20, 2014
Linking the genetic architecture of cytosine modifications with human complex traitsXu Zhang, Erika L Moen, Cong Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2011
Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O⁶-methylguanine-DNA methyltransferase and mismatch repair proteinsChristiane Querfeld, Steven T Rosen, Joan Guitart, et al.
Pageof 19

Showing results (111-120 of 188) with videos related to

Sort By:
Pageof 19
Molecular Cancer Therapeutics|December 17, 2002
O6-benzylguanine-mediated enhancement of chemotherapyHenry S Friedman, Stephen Keir, Anthony E Pegg, et al.
Scientific Reports|January 17, 2018
Gene and MicroRNA Perturbations of Cellular Response to Pemetrexed Implicate Biological Networks and Enable Imputation of Response in Lung AdenocarcinomaEric R Gamazon, Matthew R Trendowski, Yujia Wen, et al.
Biochemical Pharmacology|May 12, 2009
The kinase inhibitor O6-cyclohexylmethylguanine (NU2058) potentiates the cytotoxicity of cisplatin by mechanisms that are independent of its effect upon CDK2Luke R E Harrison, Christopher J Ottley, D Graham Pearson, et al.
Nature Reviews. Drug Discovery|July 1, 2008
Creating and evaluating genetic tests predictive of drug responseScott T Weiss, Howard L McLeod, David A Flockhart, et al.
Genetic Epidemiology|May 7, 2014
Poly-omic prediction of complex traits: OmicKrigingHeather E Wheeler, Keston Aquino-Michaels, Eric R Gamazon, et al.
Genetics|June 25, 2013
Genome-wide variation of cytosine modifications between European and African populations and the implications for complex traitsErika L Moen, Xu Zhang, Wenbo Mu, et al.
Molecular Cancer Therapeutics|July 29, 2003
Enhancement of platinum-induced cytotoxicity by O6-benzylguanineMelissa L Fishel, Shannon M Delaney, Lindsay D Friesen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2009
Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokineticsFederico Innocenti, Deanna L Kroetz, Erin Schuetz, et al.
Human Molecular Genetics|June 20, 2014
Linking the genetic architecture of cytosine modifications with human complex traitsXu Zhang, Erika L Moen, Cong Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2011
Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O⁶-methylguanine-DNA methyltransferase and mismatch repair proteinsChristiane Querfeld, Steven T Rosen, Joan Guitart, et al.
Pageof 19